press kit - CHU Amiens
Transcription
press kit - CHU Amiens
PRESS KIT December 2009, 9th Press contacts : University Hospital of Amiens Cathy Josse 03 22 66 87 83 [email protected] University Hospital of Lyon Céline Chaux-Bardyn 04 72 40 70 88 [email protected] Facial allograft (lips – chin - mandible) As the haunting memory of WWI’s broken faces remains, we are confronted with contemporary disfigurements, following a domestic accident or a traumatism, like a burn or a gun shot. Unfortunately, the immense technical progress in reconstructive microsurgery has not yet permitted, in spite of more or less elaborated autotransplants, to give these patients back a humanly visage. The huge step taken with the first facial allograft conducted on November 27th 2005 at the University Hospital of Amiens by Professors DEVAUCHELLE and TESTELIN, DUBERNARD (University Hospital of Lyon), has opened the way to new techniques in reconstructive facial surgery. Since then, 9 other facial grafts have been performed in France and in the rest of the world, including the most recent one, performed on November 2009, 27th at the University Hospital of Amiens, exactly four years after the first world allograft. The patient He is a 26-year-old man, severely disfigured by a firework explosion in May 2008. This explosion caused very severe orbital and upper face fractures, firstly operated by Dr P. JAMMET and YACHOUH at the University Hospital of Montpellier (south of France). The explosion also caused a substantial loss of tissue, since all of the lower part of the face, including lips, chin, mandible and maxillar bone were destroyed. Since the accident, the patient was not able to speak, to eat or to participate in any kind of social life. He always wore a mask and be was fed at night with a tube. Considering these facts and the very good result of the first facial allograft performed in the Amiens Hospital, in collaboration with the Lyon Hospital team, it became obvious that the best solution for the reconstruction of his face was to offer him a facial transplant of lips, chin and mandible. This man, very motivated and determined, was completely informed of this solution, the treatment, the follow up, the immunosuppressive treatment. He totally understood the risks of the surgery and immunosuppressive treatment required by the transplant. He accepted to be treated and followed up by both teams in Amiens and Lyon, on the medical and the psychological point of view. Surgical procedure Dossier de presse Harvesting of the transplant Under general anaesthesia, stem cells were firstly taken from the hips of the donor by the haematologists of the Lyon team, in order to be prepared for possible future infusions of stem cells. The transplant was surgically dissected in order to harvest the exact among of skin from the lips, chin, neck, mandible the attached muscles, salivary glands, vessels and nerves, the latter in order to restore sensibility and motricity. In particular, the facial vessels, orbital and mandible, and the sensitive nerve branches and facial nerve branches were dissected. To respect the face of the donor, the restoration of his face was realised by maxillofacial prosthetic technicians, thanks to the initial print of the face taken prior to harvesting. Shape, colour and texture of the tissues were respected thanks to the use of coloured and sophisticated silicones. These first harvesting steps did not jeopardize in any way the harvesting for other transplantations of several vital organs in this multi-organ donor. Surgery of the recipient The treatment was performed under general anaesthesia on Friday November 27th, during 19 consecutive hours. In a first stage, the surgery consisted in preparing the edge of the defect, completing the dissection of the different layers constituted by muscle, facial nerves, and bone fragments of the mandible with the sensitive nerves branches isolation of the vessels and all that before the arrival of the transplant. At that time, firstly we performed the bone synthesis just before the vascular anastomasis on the facial vessels under microscope on the left than right side. After two hours of ischemia the facial transplant was well revascularized. After the final bone fixation, muscles, nerves were carefully sutured with the corresponding anatomical element on the patient. Finally the mucosal plan was sutured in the way to restore the intra-oral watertightness. At the end, the skin was closed from the neck to the nose to obtain the best aesthetic result. All that surgery was made by maxillofacial team of Amiens with the help of Pr LENGELE of Brussels and YACHOUH from Montpellier. Post operative period Immunosuppression and follow up The immunosuppressive regimen associated first by an induction by Thymoglobuline*, Tacrolimus*, Mycophenolate mofetil* and Prednisone*. That is a strong immunosuppressive treatment because of the immunogenecity of composite tissue allograft. An infusion of stems cells has completed this treatment. Association of stem cells to prevent the rejection More than the surgical challenge, the most difficult thing for allograft of organ or composite tissue is to prevent the transplant from the rejection episode. Those could be occurred at anytime after surgery and long life time. The purpose is to induce a tolerance phenomenon in which the transplant could be accepted by the recipient immunologic system. That way it will be possible to inject some cells of the donor (cells stems) to the patient, even if the H.L.A. system are not the same. The cohabitation of those two different population of cells is named Chimerism. This medullar chimerism could be induced by infusion of stems cells of the donor harvested before the facial transplant. Protocol Stems cells of the donor had been infused to the patient at Day 4 as it was done for the first facial grafted patient. As that time a transitory chimerism occurred at Day 60. This cohabitation even for a short time could be allowed a better tolerance of the transplant. For that second case, teams agreed in a stronger protocol to induce the better chimerism. Those infusions are obviously associated with strong immunosuppression regimen for 10 days. The patient is treated and followed in the University Hospital in Lyon until a good balance of the medical treatment with less risk of acute rejection episode. Physiotherapy The patient had benefit preoperatively of an evaluation of motricity and sensibility of the face but also intensive physiotherapy to prevent muscular atrophy and scar retraction. The protocol will be continued in the same way after the graft according the evolution in the way to recover functions of mastication, phonation and aesthetic as soon as possible. RMM evaluation In few months objective evaluation of the functions will be done by MRI compared to the preoperative one according to protocol established by Pr Angela SIRIGU (Institute of cognitive sciences CNRS Lyon). Psychological follow up Despite the very important traumatism of this facial disfigurement, the patient had been very courageous and serene. Dossier de presse He also waited very patiently for transplant. He always would like to maintain his social life event if it was very difficult because of this mask and the behaviour of other people. Since now10 days, his acceptation of his new face is obvious. The team The team which realised this transplantation of lips, chin and mandible gathered around 50 people with surgeons, anaesthesiologists, nurses and prosthetic technician, all under the responsibility of Professor DEVAUCHELLE head chief of the department of maxillofacial surgery in Amiens. During the post operative period, the patient was transferred to the department of transplantology in Lyon (head chief Professor Xavier MARTIN and Jean Michel DUBERNARD) for the immunosuppressive treatment and follow up in collaboration with Professor MICHALLET (heamatologist) and her team, as well as all the other specialists involved : psychiatrists, phoniatrists, haematologists and researchers…. AMIENS Bernard DEVAUCHELLE Coordination Ghassan BITAR, surgeon Pierrick BOUTE, surgeon Sophie CARTON , surgeon Kamel CHEBOUBI, anaesthesiologist Sophie CREMADES, psychistrist Stéphanie DAKPE, surgeon Corentin DENGLEHEM, surgeon Evgeny DIMOV, anaesthesiologist Olivier DUNAUD, surgeon Benjamin GUICHARD, surgeon Sebastien LAVAQUERIE, surgeon Audrey LEMAIRE, surgeon Anthony MARTON , prosthetic technician Cecilia NEIVA, surgeon Johann ORYE, surgeon Farid TAHA, surgeon Sylvie TESTELIN, surgeon Jean TCHAOUSSOFF, coordination anaesthesiologist – intensive care Elie ZOGHEIB, anaesthesiologist UCL BRUXELLES Benoit LENGELE, surgeon CHU MONTPELLIER Jacques YACHOUH, surgeon LYON JM DUBERNARD Coordination Lionel BADET, transplantology Jean –Luc BEZIAT, maxillo-facial surgeon Maria BRUNET, transplantology Assia EL JAAFARI, immunology Olivier HEQUET, cellular therapy Jean KANITAKIS, dermatology Pascale LABUSSIERE ,hematologist Xavier MARTIN, transplantology Mauricette MICHALLET, hematologist Emmanuel MORELON, transplantology Emmanuelle NICOLAS, hematologist Olivier DUBOSC de PESQUIDOUX, coordination Palmina PETRUZZO, transplantology Christophe SEULIN , psychiatrist Angela SIRIGU, neuroscience Medical, ethical and psychological aspects As in the case of the first facial graft, (nose-lips-chin) in 2005, the Agency of Biomedecine requested that all medical, ethical and psychological expertise be properly conducted, in a way that all respects are paid to the donor family and to the patient. Dossier de presse The facial allograft (lips-chin-mandible) is possible after several expertises. The Amiens and Lyon teams submitted a specific request to the Agency of Biomedicine, concerning the facial composite graft for a 26-year-old patient, whose face was severely wounded by an explosion. More than an important esthetical prejudice, this lesion led to a complete oral incompetence, without any possibility to eat or speak. Like organ transplants, composite grafts are under the responsibility of the Agency of Biomedecine, which manages this type of harvesting and distribution of graft. This facial transplant was requested through the national protocol of research (P.H.R.C.) attributed to the Amiens team in 2006 and confirmed by the AFSSAPS. The Agency of Biomedecine verified that the harvestement of the facial transplant did not impair the multi organharvestement. The surgical teams were very cautious to prepare a protocol which included the possibility to harvest all other organs. In fact, great care was taken not to lose any organ, which is very precious. Nowadays, even if there is a real improvement of organ donation in France, donors are scarce. All medical teams are always concerned with this request of organ. The Agency of Biomedecine controlled that satisfying means were available to reconstitute the donor’s face. The Agency of Biomedecine paid special attention to the fact that the donor’s face reconstruction was faithful to its state before the harvesting. The expertise of the maxillo facial department, in terms of prothesists, allowed the best solution for this restoration in terms of shape, volume, colour, thanks to a first print of the face, taken prior to surgery. The donor’s body was fully respected. The Agency of Biomedecine controlled that there will be a psychological follow up of the patient and the relatives of the donor. All things were managed in the way that the patient could be clearly .and totally informed of the surgical procedure, the risks and constraints associated to the long life immunosuppressive treatment. The patient agreed and signed the information-and-consent form for this protocol. Following a similar purpose, the Agency controlled that there will be a psychological follow up of the relatives of the donor, if needed. Dossier de presse The donor’s family could be informed and followed by a coordinating doctor and nurses. All the medical teams have carefully explained the situation to the family. All procedures depend on the expertise and competency of the hospital coordination. The teams are specifically prepared and trained to help the family in this difficult decision. Annex (Dr Taha Amiens) Figure 1 : Figure 2 : Figure 3 :